ALLOPURINOL Tablets 100 mg Milligram

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

ALLOPURINOL

Available from:

Roussel Laboratories Limited

Dosage:

100 mg Milligram

Pharmaceutical form:

Tablets

Authorization date:

1988-07-25

Summary of Product characteristics

                                PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Allopurinol Tablets 100mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 100mg of Allopurinol 
For excipients, see 6.1.
3 PHARMACEUTICAL FORM
Tablets
White biconvex tablets about 9.5mm in
diameter. One face is marked
with ‘AP’, a breakline and ‘100’, the reverse 
carries the Roussel logo.
4 CLINICAL PARTICULARS 
4.1 THERAPEUTIC INDICATIONS
1.
In the management of conditions of excess body urate, including
gout, neoplastic disease and associated treatment, 
enzyme disorders such as the Lesch – Nyhan Syndrome,
renal calculi, renal failure, diuretic therapy and psoriasis.
2.
In the prophylaxis and treatment of calcium renal lithiasis in
patients with raised serum or urinary uric acid.
4.2 POSOLOGY AND METHOD OF ADMINSTRATION
DOSAGE:
Adults:
The usual daily dose is 300mg as a single dose with
increments, as indicated by monitoring of serum and/or urinary 
uric acid, to the level necessary for optimum control, seldom in
excess of 900mg. Dosage higher than 300mg should be 
given in divided doses not exceeding 300mg at any one time.
Children:
The usual daily dose is 10 to 20 mg/kg b.w.
To avoid an acute attack of gouty arthritis in
the initial stages of treatment,
colchicine or other appropriate agents 
should be given for at least a month. When used in
neoplasia allopurinol therapy should be commenced before 
cytotoxics. 
In renal insufficiency, dosage requirements must be reduced
if creatinine clearance is less than 20ml/minute.
CREATININE CLEARANCE 
DOSAGE
10-20 ml/min
100 to 200mg daily
<10ml/min
100mg daily or at longer intervals
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Issued 25/08/2005_
_CRN 2014137_
_page number: 1_
If frequent renal dialysis is require
                                
                                Read the complete document
                                
                            

Search alerts related to this product